Guidelines for Authors
Asian Journal of Biomedical and Pharmaceutical Sciences (AJBPS) is an international multidisciplinary monthly Journal, which publishes original research article, short communications, invited reviews, Opinions & Perspectives and Book Reviews in biomedical and pharmaceutical sciences.
Authors are encouraged to read instructions carefully before submitting the manuscript. For submitting the manuscript authors are encouraged to use online submission process by logging in to www.jbiopharm.com where they also can keep track with the status of the manuscript.
Submitted manuscripts are subject to peer review. Submitted articles will be typically peer reviewed and published within 10-15 days after acceptance. Prior to publication, the final version of the edited article will be sent to authors for approval. Authors must check for accuracy of all content at this time.
You may submit manuscripts through online prtal by using this link https://www.scholarscentral.org/submissions/asian-biomedical-pharmaceutical-sciences.html or as an email attachment to the following mail ids: [email protected]
Asian journal of biomedical and pharmaceutical Sciences is a scholarly open access journal that follows double blind process. The journal aims to publish information on the discoveries and current novel developments in the mode of original articles, review articles, case reports, short communications, etc. while making them freely available through online without any restrictions or any other subscriptions to researchers worldwide. It is a scholarly publishing journal, where the editorial office follows a preliminary quality control check followed by double blind peer review process for acquired articles to avail quality protocol on publishing the submitted manuscripts.
Journal publishes Manuscript of following types:
Original research article: Original Research article should include Title, Abstract, Methods and Materials, Results, Discussion, Conclusions, Acknowledgements and References. Manuscript should not be exceeding 15 typewritten pages including tables and figures.
Short communications: Short communications presenting important new finding and cannot be elaborated as full research paper can be communicated whose average length is not more than 6 type-written pages (Approx-2500 words), including abstract and title page.
Invited reviews: Reviews on special topics of current interest in biomedical and pharmaceutical sciences are welcomed. Length of review article should be same as that of original research article.
Opinions & Perspectives: Opinions & perspectives on topics of current and future interest by renowned scientist, researchers are welcomed.
Book Reviews in Biomedical and Pharmaceutical sciences: Books for review should be sent to the Reviews Editor Preparation of Manuscripts:
General requirements: Manuscripts must be prepared in accordance with "Uniform requirements for Manuscripts submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (October 2006).
Manuscripts should be type written in Times New Roman, font 12, Title shall be in a font size 14. All section titles in the manuscript shall be in font size 12, bold face capitals. Subtitles in each section shall be in font size 12, bold face lower case followed by a colon. Double spacing all portions of the manuscript- including the title page, abstract, text, acknowledgments, references, individual tables, and legends-and margins 2.5 cm each side. Authors should number all of the pages of the manuscript consecutively, beginning with the title page.
Authors, in their cover letter to the Editor, should clearly mention whether the manuscript shall be considered as an original Research article, Short Communication or Review Article and also confirm that the manuscript has not been submitted to any other Journal for publication. Authors publishing results from in vivo experiments involving animals or humans should state whether due permission for conduction of these experiments was obtained, from the relevant ethics committees, in the Materials and Methods section.
Publication Ethics and Malpractice Guildelines
Duties of Editors
Asian Journal of Biomedical and Pharmaceutical Sciences editors are responsible for deciding which of the articles submitted to the journal should be published in current volume of the journal. Editor may be guided by the policies of the journal’s editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism.
Asian Journal of Biomedical and Pharmaceutical Sciences editor at any time evaluate manuscripts for their intellectual content without regard to the nature of the authors or the host institution including race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.
Asian Journal of Biomedical and Pharmaceutical Sciences editor must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author.
When genuine errors in published work are pointed out by readers, authors, or members of editorial board, which do not render the work invalid, a correction (or erratum) will be published as soon as possible. The online version of the paper may be corrected with a date of correction and a link to the printed erratum. If the error renders the work or substantial parts of it invalid, the process of retraction can be initiated. In such case, the retraction communication with explanations as to the reason for retraction will be published as soon as possible. Consequently, the message about retraction will be indicated on article page and in PDF version of retracted article.
If serious concerns are raised by readers, reviewers, or others, about the conduct, validity, or reporting of academic work, editor will initially contact the authors and allow them to respond to the concerns. If that response is unsatisfactory, allied academies will take this to the institutional level.
Asian Journal of Biomedical and Pharmaceutical Sciences will respond to all allegations or suspicions of research or publication misconduct raised by readers, reviewers, or other editors. Cases of possible plagiarism or duplicate/redundant publication will be assessed by the journal. In other cases, allied academies may request an investigation by the institution or other appropriate bodies (after seeking an explanation from the authors first and if that explanation is unsatisfactory).
Retracted papers will be retained online, and they will be prominently marked as a retraction in all online versions, including the PDF, for the benefit of future readers.
Duties of Reviewers
Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor’s attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
Editor will take reviewer misconduct seriously and pursue any allegation of breach of confidentiality, non-declaration of conflicts of interest (financial or non-financial), inappropriate use of confidential material, or delay of peer review for competitive advantage. Allegations of serious reviewer misconduct, such as plagiarism, will be taken to the institutional level.
Duties of Authors
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.
Authors should ensure that submitted work is original and has not been published elsewhere in any language, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.
Applicable copyright laws and conventions should be followed. Copyright material (e.g. tables, figures or extensive quotations) should be reproduced only with appropriate permission and acknowledgement.
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors.
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.
For animal and clinical experiments - There must be a clear statement while submitting that, investigations using experimental animals were conducted in accordance with the internationally accepted principles for laboratory animal use and care as found in for example the European Community guidelines (EEC Directive of 1986; 86/609/EEC) or the US guidelines (NIH publication #85-23, revised in 1985). Investigations with human subjects must state that the research followed guidelines of the Declaration of Helsinki and Tokyo for humans, and was approved by the institutional human experimentation committee or equivalent, and that informed consent was obtained. For reports of randomized, controlled trials, authors should refer to the CONSORT statement. This guideline provides a set of recommendations comprising a list of items to report and a patient flow diagram.
Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA (animal) and ICMR (human). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section
Article Processing Charges (APC)
Average Article prorcessing time (APT) is 55 days
Preparation of Manuscripts: Original Research Article
Original research article should be divided into the following sections
The title page should have the following information:
Article title. Concise titles are easier to read than long, convoluted ones. Titles that are too short may, however, lack important information, such as study design (which is particularly important in identifying randomized, controlled trials). Authors should include all information in the title that will make electronic retrieval of the article both sensitive and specific.
Authors’ names and institutional affiliations. Some journals publish each author’s highest academic degree(s), while others do not.
The name of the department(s) and institution(s) to which the work should be attributed.
Disclaimers, if any.
Contact information for corresponding authors. The name, mailing address, telephone and fax numbers, and e-mail address of the author responsible for correspondence about the manuscript (the “corresponding author;” this author may or may not be the “guarantor” for the integrity of the study).
Source(s) of support in the form of grants, equipment, drugs, or all of these.
A running head.
The number of figures and tables.
Conflict-of-Interest Notification To prevent the information on potential conflicts of interest from being overlooked or misplaced, it needs to be part of the manuscript. However, it should also be included on a separate page or pages immediately following the title page.
The abstract should follow the title page. It should provide the context or background for the study and should state the study’s purpose, basic procedures (selection of study subjects or laboratory animals, observational and analytical methods), main findings (giving specific effect sizes and their statistical significance, if possible), and principal conclusions. It should emphasize new and important aspects of the study or observations. Articles on clinical trials should contain abstracts that include the items that the CONSORT group has identified as essential (www.consort-statement.org/?_1190).
Provide a context or background for the study (that is, the nature of the problem and its significance). State the specific purpose or research objective of, or hypothesis tested by, the study or observation; the research objective is often more sharply focused when stated as a question. Both the main and secondary objectives should be clear, and any pre-specified subgroup analyses should be described. Provide only directly pertinent references, and do not include data or conclusions from the work being reported.
The Methods section should include only information that was available at the time the plan or protocol for the study was being written; all information obtained during the study belongs in the Results section.
Selection and Description of Participants
Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. The guiding principle should be of clarity about how and why a study was done in a particular way.
Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow others to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well-known; describe new or substantially modified methods, give the reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration. Authors submitting review manuscripts should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.
Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as P values, which fail to convey important information about effect size. References for the design of the study and statistical methods should be to standard works when possible (with pages stated). Define statistical terms, abbreviations, and most symbols. Specify the computer software used.
Present your results in logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat all the data in the tables or illustrations in the text; emphasize or summarize only the most important observations. Extra or supplementary materials and technical detail can be placed in an appendix where they will be accessible but will not interrupt the flow of the text, or they can be published solely in the electronic version of the journal. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess supporting data.
Emphasize the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other information given in the Introduction or the Results section. For experimental studies, it is useful to begin the discussion by summarizing briefly the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data. In particular, avoid making statements on economic benefits and costs unless the manuscript includes the appropriate economic data and analyses.
Each page (A4) will be charged to authors at Euro 519.00. Euro 1019.00 will be charged for a short paper of 1-3 pages. For each image additional Euro 200.00 will be charged to the authors. Payment may be made before publishing the manuscript/s. In special cases page charge may be reduced.
General Considerations Related to References
Small numbers of references to key original papers often serve as well as more exhaustive lists, particularly since references can now be added to the electronic version of published papers, and since electronic literature searching allows readers to retrieve published literature efficiently.
Information from manuscripts submitted but not accepted should be cited in the text as “unpublished observations” with written permission from the source.
Avoid citing a “personal communication” unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text.
Reference Style and Format
Authors should consult NLM’s Citing Medicine for information on its recommended formats for a variety of reference types. References should be numbered consecutively in the order in which they are first mentioned in the text.
Identify references in text, tables, and legends by Arabic numerals in parentheses. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure.
The titles of journals should be abbreviated according to the style used in the list of Journals Indexed for MEDLINE, posted by the NLM on the Library’s Web site.
For quick review of style authors can use following referencing format
1. Davidoff F, for the CSE Task Force on Authorship. Who’s the author? Problems with biomedical authorship and some possible solutions. Science Editor. 2000; 23:111-9.
2. Yank V, Rennie D. Disclosure of researcher contributions: a study of original research articles in The Lancet. Ann Intern Med. 1999;130:661-70.
3. Flanagin A, Fontanarosa PB, DeAngelis CD. Authorship for research groups. JAMA. 2002;288:3166-8.
4. Godlee F, Jefferson T. Peer Review in Health Sciences. London: BMJ Books; 1999.
5. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2000;284:3043-5.
6. Pitkin RM, Branagan MA, Burmeister LF. Accuracy of data in abstracts of published research articles. JAMA. 1999; 281:1110-1.
Tables capture information concisely and display it efficiently; they also provide information at any desired level of detail and precision. Type each table with double spacing on a separate sheet of paper.
Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Give each column a short or an abbreviated heading. Authors should place explanatory matter in footnotes, not in the heading. Explain all nonstandard abbreviations in footnotes, and use the following symbols, in sequence: *, †, ‡, •, ||, â€£, **, ††, ‡‡ Identify statistical measures of variations, such as standard deviation and standard error of the mean. Be sure that each table is cited in the text.
Units of Measurement
Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be in degrees Celsius. Blood pressures should be in millimeters of mercury, unless other units are specifically required by the journal.
Abbreviations and Symbols
Use only standard abbreviations; use of nonstandard abbreviations can be confusing to readers. Avoid abbreviations in the title of the manuscript. The spelled-out abbreviation followed by the abbreviation in parenthesis should be used on first mention unless the abbreviation is a standard unit of measurement. Other types of articles, such as case reports, reviews, and editorials, probably need to be formatted differently.
Electronic proofs will be sent (e-mail attachment) to the corresponding author as a PDF file. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Authors will have free electronic access to the full text (in both HTML and PDF) of the article. Authors can freely download the PDF file from which they can print unlimited copies of their articles.
EReprints may be purchased. Order for supply of reprints may be sent while returning the galley proofs after corrections. No reprint/s will be supplied free of charge. Reprint Order Form and Price List will be sent with the galley proofs.
Transfer of Copyright Agreement:
Submission of a manuscript implies: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) that it is not under consideration for publication elsewhere; that if and when the manuscript is accepted for publication, the authors agree to automatic transfer of the copyright to the publisher.
All accepted manuscript must be accompanied by a signed copyright form to progress through to the final stages of production.